Gilteritinib is a tyrosine kinase inhibitor that is approved for acute myeloma leukemia patients who are FLT-3 positive. It is currently being studied for use in several different indications.
| SparkCures ID | 554 |
|---|---|
| Brand Name | Xospata® |
| Generic Name | Gilteritinib |
| Treatment Classifications | |
| Treatment Targets |
|
There are no resources, links or videos to display for this treatment.